QuantumSi is trading 12.2% down at $1.15 on October 16, 2026, amid broader selling pressure, with no clear company-specific negative catalyst identified.
- The biotech sector is down about 2.1%; market reports cite technology weakness and investor concerns about AI-related debt weighing on stocks.
- QuantumSi will report third-quarter results on November 5; that scheduling update does not explain the decline. Nasdaq minimum-bid compliance had already been restored, according to an October 15 announcement.